Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial)

Peer Review reports

Original Submission
17 Jun 2020	Submitted	Original manuscript
11 Oct 2020	Reviewed	Reviewer Report - Riaz Qureshi
11 Oct 2020	Reviewed	Reviewer Report - Shengyuan Luo
25 Nov 2020	Author responded	Author comments - Raymond Chan
Resubmission - Version 2
25 Nov 2020	Submitted	Manuscript version 2
Publishing
1 Dec 2020	Editorially accepted
6 Jan 2021	Article published	10.1186/s13063-020-04945-4

Back to article page